
### [NCIT:C7614](http://purl.obolibrary.org/obo/NCIT_C7614)
**Label:** Cutaneous Lymphoproliferative Disorder

**Subclasses:** [NCIT:C3467](http://purl.obolibrary.org/obo/NCIT_C3467) (Primary Cutaneous T-Cell Non-Hodgkin Lymphoma), [NCIT:C6859](http://purl.obolibrary.org/obo/NCIT_C6859) (Grade 3 Cutaneous Follicular Lymphoma), [NCIT:C6858](http://purl.obolibrary.org/obo/NCIT_C6858) (Primary Cutaneous B-Cell Non-Hodgkin Lymphoma), [NCIT:C45241](http://purl.obolibrary.org/obo/NCIT_C45241) (Cutaneous B Lymphoblastic Leukemia/Lymphoma), [NCIT:C45163](http://purl.obolibrary.org/obo/NCIT_C45163) (Borrelia Burgdoferi-Associated Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C45242](http://purl.obolibrary.org/obo/NCIT_C45242) (Cutaneous T Lymphoblastic Leukemia/Lymphoma), [NCIT:C45366](http://purl.obolibrary.org/obo/NCIT_C45366) (Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder), [NCIT:C45249](http://purl.obolibrary.org/obo/NCIT_C45249) (Cutaneous Mature B-Cell Neoplasm), [NCIT:C7221](http://purl.obolibrary.org/obo/NCIT_C7221) (Primary Cutaneous Hodgkin Lymphoma), [NCIT:C7220](http://purl.obolibrary.org/obo/NCIT_C7220) (Grade 1 Cutaneous Follicular Lymphoma), [NCIT:C7195](http://purl.obolibrary.org/obo/NCIT_C7195) (Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder), [NCIT:C35794](http://purl.obolibrary.org/obo/NCIT_C35794) (Pagetoid Reticulosis), [NCIT:C27365](http://purl.obolibrary.org/obo/NCIT_C27365) (Adult Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C45250](http://purl.obolibrary.org/obo/NCIT_C45250) (Cutaneous Mature T-Cell and NK-Cell Neoplasm), [NCIT:C138027](http://purl.obolibrary.org/obo/NCIT_C138027) (Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type), [NCIT:C7798](http://purl.obolibrary.org/obo/NCIT_C7798) (Stage II Mycosis Fungoides), [NCIT:C138028](http://purl.obolibrary.org/obo/NCIT_C138028) (Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type), [NCIT:C6860](http://purl.obolibrary.org/obo/NCIT_C6860) (Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C8687](http://purl.obolibrary.org/obo/NCIT_C8687) (Refractory Mycosis Fungoides), [NCIT:C45332](http://purl.obolibrary.org/obo/NCIT_C45332) (Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype), [NCIT:C45214](http://purl.obolibrary.org/obo/NCIT_C45214) (Primary Cutaneous Intravascular Large B-Cell Lymphoma), [NCIT:C7796](http://purl.obolibrary.org/obo/NCIT_C7796) (Stage I Mycosis Fungoides), [NCIT:C8686](http://purl.obolibrary.org/obo/NCIT_C8686) (Recurrent Mycosis Fungoides), [NCIT:C45213](http://purl.obolibrary.org/obo/NCIT_C45213) (Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other), [NCIT:C7197](http://purl.obolibrary.org/obo/NCIT_C7197) (Type A Lymphomatoid Papulosis), [NCIT:C45216](http://purl.obolibrary.org/obo/NCIT_C45216) (Primary Cutaneous Plasmablastic Lymphoma), [NCIT:C7230](http://purl.obolibrary.org/obo/NCIT_C7230) (Primary Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C45215](http://purl.obolibrary.org/obo/NCIT_C45215) (Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma), [NCIT:C7196](http://purl.obolibrary.org/obo/NCIT_C7196) (Borderline Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder), [NCIT:C7199](http://purl.obolibrary.org/obo/NCIT_C7199) (Type C Lymphomatoid Papulosis), [NCIT:C45339](http://purl.obolibrary.org/obo/NCIT_C45339) (Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma), [NCIT:C7198](http://purl.obolibrary.org/obo/NCIT_C7198) (Type B Lymphomatoid Papulosis), [NCIT:C7162](http://purl.obolibrary.org/obo/NCIT_C7162) (Primary Cutaneous Lymphoma), [NCIT:C3721](http://purl.obolibrary.org/obo/NCIT_C3721) (Lymphomatoid Papulosis), [NCIT:C8938](http://purl.obolibrary.org/obo/NCIT_C8938) (Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma), [NCIT:C7802](http://purl.obolibrary.org/obo/NCIT_C7802) (Stage IV Mycosis Fungoides), [NCIT:C3246](http://purl.obolibrary.org/obo/NCIT_C3246) (Mycosis Fungoides), [NCIT:C7805](http://purl.obolibrary.org/obo/NCIT_C7805) (Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma), [NCIT:C45340](http://purl.obolibrary.org/obo/NCIT_C45340) (Primary Cutaneous Gamma-Delta T-Cell Lymphoma), [NCIT:C7800](http://purl.obolibrary.org/obo/NCIT_C7800) (Stage III Mycosis Fungoides), [NCIT:C45264](http://purl.obolibrary.org/obo/NCIT_C45264) (Cutaneous Chronic Lymphocytic Leukemia), [NCIT:C45267](http://purl.obolibrary.org/obo/NCIT_C45267) (Cutaneous Lymphomatoid Granulomatosis), [NCIT:C45266](http://purl.obolibrary.org/obo/NCIT_C45266) (Cutaneous Mantle Cell Lymphoma), [NCIT:C45268](http://purl.obolibrary.org/obo/NCIT_C45268) (Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma), [NCIT:C6918](http://purl.obolibrary.org/obo/NCIT_C6918) (Subcutaneous Panniculitis-Like T-Cell Lymphoma), [NCIT:C45193](http://purl.obolibrary.org/obo/NCIT_C45193) (Primary Cutaneous Diffuse Large B-Cell Lymphoma), [NCIT:C7219](http://purl.obolibrary.org/obo/NCIT_C7219) (Grade 2 Cutaneous Follicular Lymphoma), [NCIT:C45194](http://purl.obolibrary.org/obo/NCIT_C45194) (Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type), [NCIT:C45271](http://purl.obolibrary.org/obo/NCIT_C45271) (Cutaneous Angioimmunoblastic T-Cell Lymphoma), [NCIT:C5631](http://purl.obolibrary.org/obo/NCIT_C5631) (Aleukemic Acute Lymphoblastic Leukemia Cutis), [NCIT:C7218](http://purl.obolibrary.org/obo/NCIT_C7218) (Cutaneous Follicular Lymphoma), [NCIT:C7217](http://purl.obolibrary.org/obo/NCIT_C7217) (Primary Cutaneous Follicle Center Lymphoma), [NCIT:C139014](http://purl.obolibrary.org/obo/NCIT_C139014) (Type D Lymphomatoid Papulosis), [NCIT:C7211](http://purl.obolibrary.org/obo/NCIT_C7211) (Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C139015](http://purl.obolibrary.org/obo/NCIT_C139015) (Type E Lymphomatoid Papulosis), [NCIT:C45238](http://purl.obolibrary.org/obo/NCIT_C45238) (Cutaneous Precursor Lymphoid Neoplasm), [NCIT:C39644](http://purl.obolibrary.org/obo/NCIT_C39644) (Mycosis Fungoides Variant), 

**Class expressions from DL-Learner:**

- [UBERON:0002465](http://purl.obolibrary.org/obo/UBERON_0002465) (lymphoid system) 58.33%
- [UBERON:0002097](http://purl.obolibrary.org/obo/UBERON_0002097) (skin of body) 58.33%
- Thing 51.96%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 44.84%
- [CL:0000763](http://purl.obolibrary.org/obo/CL_0000763) (myeloid cell) 27.23%
- [CL:0000988](http://purl.obolibrary.org/obo/CL_0000988) (hematopoietic cell) 25.18%
- [CL:0002371](http://purl.obolibrary.org/obo/CL_0002371) (somatic cell) 22.42%
- [CL:0000255](http://purl.obolibrary.org/obo/CL_0000255) (eukaryotic cell) 22.21%
- [CL:0000003](http://purl.obolibrary.org/obo/CL_0000003) (native cell) 21.91%
- [GO:0005623](http://purl.obolibrary.org/obo/GO_0005623) (cell) 21.89%
- [CL:0000000](http://purl.obolibrary.org/obo/CL_0000000) (cell) 21.80%
- [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) 21.51%
- [CL:0002087](http://purl.obolibrary.org/obo/CL_0002087) (nongranular leukocyte) 15.87%
- [CL:0000542](http://purl.obolibrary.org/obo/CL_0000542) (lymphocyte) 15.87%
- [CL:0002242](http://purl.obolibrary.org/obo/CL_0002242) (nucleate cell) 15.79%


